U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. April 25, 2023: Conversations on Cancer: “Beginning the Rare Cancer Journey: Charting the Best Path to an Accurate Diagnosis” - 04/25/2023
  1. FDA Meetings, Conferences and Workshops

Virtual | Virtual

Event Title
April 25, 2023: Conversations on Cancer: “Beginning the Rare Cancer Journey: Charting the Best Path to an Accurate Diagnosis”
April 25, 2023

Date:
April 25, 2023
Time:
2:00 p.m. - 3:00 p.m. ET
Image
OCE_Conversations-Rare-Cancer-Social-Media-Twitter-and-Reg

Twitter: #ConversationsOnCancer

Background:

The FDA Oncology Center of Excellence (OCE) is excited to present a Conversations on Cancer titled “Beginning the rare cancer journey: charting the best path to an accurate diagnosis”. Join this 1-hour informal panel discussion featuring perspectives from patients with rare cancers and researchers and clinicians in the field. This public panel discussion is designed to bring greater awareness to the challenges to receiving the correct diagnosis experienced by some patients with rare cancers, and highlight opportunities and strategies to address these challenges in the era of personalized medicine.

Important issues that will be covered include:

  • Patient, clinician, and pathologist perspectives on the difficulties associated with diagnosing some rare cancers
  • Patient perspectives on the impact of delays in their rare cancer diagnosis
  • Importance of timely access to appropriate diagnostic testing
  • Barriers to correct diagnosis of rare cancers and ways to help overcome these barriers

Webcast Information:

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.

FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

 

Back to Top